← Leaderboards
Chrystal U Louis
Baylor College Of Medicine
$26,349
Attributed
$26,349
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $14.9K · FY2009–11$20K$15K$10K$5K$0
'09
'10
'11
Funding mix
By agency
NIH$26,349 · 7
By mechanism
M01$26,349 · 7
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Helen E Heslop$25,308,937
- Cliona M Rooney$13,445,584
- Malcolm K Brenner$13,204,649
- Stephen Gottschalk$13,145,706
- Milan Alexander Jamrich$7,502,046
Others in their field
Top investigators on “Funding”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,479,940,681
- Leonard Freedman · Leidos Biomedical Research, Inc.$968,195,877
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Jeffrey P Krischer · University Of South Florida$358,470,093
Research focus
FundingSourceGrantResourcesUnited States National Institutes Of HealthNeuroblastomaAutologousDoseSafetyTumorVaccinesClinical ResearchCytokineHigh RiskCellsComputer Retrieval Of Information On Scientific Projects DatabaseInstitutionClinical EfficacyAllogenicGene-ModifiedResearch PersonnelChemotherapyChemokineCell Type
Grant awards (7)
A PHASE I/II STUDY OF IMMUNIZATION WITH LYMPHOTACTIN AND INTERLEUKIN 2 GENE MODI$5,541
M01 · FY2011 · RR · contact PI
A PHASE I/II STUDY USING ALLOGENEIC TUMOR CELL VACCINATION$1,979
M01 · FY2011 · RR · contact PI
CLINICAL TRIAL: ADMINISTRATION OF PERIPHERAL BLOOD T-CELLS AND EBV SPECIFIC CTLS$395
M01 · FY2011 · RR · contact PI
A PHASE I/II STUDY OF IMMUNIZATION WITH LYMPHOTACTIN AND INTERLEUKIN 2 GENE MODI$9,920
M01 · FY2010 · RR · contact PI
CLINICAL TRIAL: ADMINISTRATION OF PERIPHERAL BLOOD T-CELLS AND EBV SPECIFIC CTLS$4,959
M01 · FY2010 · RR · contact PI
CLINICAL TRIAL: ADMINISTRATION OF PERIPHERAL BLOOD T-CELLS AND EBV SPECIFIC CTLS$2,666
M01 · FY2009 · RR · contact PI
A PHASE I/II STUDY OF IMMUNIZATION WITH LYMPHOTACTIN AND INTERLEUKIN 2 GENE$889
M01 · FY2009 · RR · contact PI